In this educational video, Dr. Kellie Smith—a leading researcher at Johns Hopkins Medicine—explains how immunotherapy is revolutionizing lung cancer treatment.
Discover how immunotherapy works, who it's most effective for, and how it's extending survival while reducing side effects. Dr. Smith breaks down key concepts, including:
How checkpoint inhibitors like PD-1 and PD-L1 blockers help T-cells attack cancer
Why immunotherapy is becoming a first-line treatment for some patients
The role of biomarkers and genetic mutations in determining treatment options
Whether you’re a patient, caregiver, or just curious about breakthroughs in cancer care, this video offers a clear, expert-guided look at the science behind immunotherapy and its growing impact on lung cancer.
#Immunotherapy #LungCancer #CancerResearch #LungCancerTreatment
Discover how immunotherapy works, who it's most effective for, and how it's extending survival while reducing side effects. Dr. Smith breaks down key concepts, including:
How checkpoint inhibitors like PD-1 and PD-L1 blockers help T-cells attack cancer
Why immunotherapy is becoming a first-line treatment for some patients
The role of biomarkers and genetic mutations in determining treatment options
Whether you’re a patient, caregiver, or just curious about breakthroughs in cancer care, this video offers a clear, expert-guided look at the science behind immunotherapy and its growing impact on lung cancer.
#Immunotherapy #LungCancer #CancerResearch #LungCancerTreatment
- Category
- Oncology

Be the first to comment